During the past decade, Central Ohio Breast and Endocrine Surgery conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 3 clinical trials were completed, i.e. on average, 7.3% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 3 clinical trials were completed. i.e. 15.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Ohio Breast and Endocrine Surgery" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "GOG Foundation" with 5 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Ohio Breast and Endocrine Surgery" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Central Ohio Breast and Endocrine Surgery" are "Stage IV Lung Cancer AJCC v8" (6 trials), "Stage IIIB Lung Cancer AJCC v8" (4 trials), "Stage IVA Lung Cancer AJCC v8" (4 trials), "Stage IVB Lung Cancer AJCC v8" (4 trials) and "Chronic Lymphocytic Leukemia" (3 trials). Many other conditions were trialed in "Central Ohio Breast and Endocrine Surgery" in a lesser frequency.

Most popular intervention types in "Central Ohio Breast and Endocrine Surgery" are "Drug" (37 trials), "Other" (23 trials), "Biological" (22 trials), "Procedure" (15 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (14 trials), "Questionnaire Administration" (12 trials), "Biospecimen Collection" (11 trials), "Computed Tomography" (11 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Central Ohio Breast and Endocrine Surgery" are 38 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Central Ohio Breast and Endocrine Surgery". undefined are not yet recruiting, 27 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Central Ohio Breast and Endocrine Surgery, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Central Ohio Breast and Endocrine Surgery, 2 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".